Machine Learning to mRNA: How I Built a Personalised Cancer Vaccine for My Dog
About the event
Speaker bio:
• Paul Conyngham is the founder of Gamgee, a Y Combinator company developing personalised mRNA cancer vaccines for dogs. After 17 years in machine learning, Paul taught himself genomics and used AI to design a personalised vaccine for his dog Rosie, whose responsive tumours shrank by 50–75%.
Presentation outline: • Rosie’s cancer and why existing treatments were not enough • Using AI to cross from machine learning into genomics • The journey from tumour sequencing to an administered mRNA vaccine • What worked\, what failed and what one patient can teach us • Turning a year-long manual process into repeatable software • Why Gamgee is starting with dogs and where the technology goes next
• Join our community on Linkedin https://www.linkedin.com/groups/14297125/ to stay up-to-date on all our upcoming events
